A medicine distributor displays Mounjaro (tirzepatide) self-injecting GLP-1 prefilled pens at his office in Thane on March 20, 2026. A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired on March 20, 2026. (Credit: Photo by Indranil MUKHERJEE / AFP via Getty Images)
The Briefing:
Sign up to read this article
Read news from 100's of titles, curated specifically for you.